MLXIPL and metabolic dysfunction-associated steatotic liver disease: In conditions of hyperglycemia, the transcriptional coactivator p300 acetylates the carbohydrate-responsive element-binding protein (ChREBP) and implicitly increases lipogenic activity, which eventually leads to NAFLD installation [17,196].